NCT07207707View on ClinicalTrials.gov

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

PHASE1RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 16, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

March 31, 2027

Conditions
Solid Tumor Malignancies
Interventions
DRUG

KQB548

Oral KQB548

Trial Locations (5)

22031

RECRUITING

NEXT Virginia, Fairfax

49546

RECRUITING

START Midwest, Grand Rapids

75039

RECRUITING

NEXT Oncology - Dallas, Irving

78229

RECRUITING

NEXT Oncology - San Antonio, San Antonio

78758

RECRUITING

NEXT Oncology - Austin, Austin

Sponsors
All Listed Sponsors
lead

Kumquat Biosciences Inc.

INDUSTRY

NCT07207707 - A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies | Biotech Hunter | Biotech Hunter